**Abstract**

**Objectives:** Persistent glucocorticoids (GCs) exposure in chronic stressful stimuli has deleterious effects on the function of neuron and microglia, leading to major depression. In the previous study, we reported that the dysregulation of microglia functional phenotype in chronic stress mice was associated with stress vulnerability and depression relapse. However, the underlying mechanism of glucocorticoid on microglia functional phenotype was not elucidated until now.

**Methods:** Rat primary microglial cells were enriched in vitro using the shaking method described by Giulian and Baker. After dexamethasone (DEX, glucocorticoid receptor agonist) treatment in primary cultured microglia, the microglia was isolated and qPCR, immunofluorescence study, and western blot were performed to investigate an alteration of microglia functional phenotype. The release factors in microglia were analyzed using ELISA and multiplex assay.

**Results:** In this study, we found that 72h of DEX treatment reduced fractalkine receptor (CX3CR1) and CD200 receptor (CD200R) in primary cultured microglia while 24h of DEX did not. In addition, the effect was abolished by RU386 (Gc antagonist) co-treatment, suggesting that glucocorticoid receptor (GR) mediates the dexamethasone effect on CX3CR1 reduction in microglia. Interestingly, we found that 72 h of DEX treatment decreased both pro-and anti-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-10, TGF-β, IGF-1) expression and secretion in microglia. The NF-kB signaling pathway was not changed by DEX treatment.

**Conclusion:** Overall, our results suggest that chronic glucocorticoid exposure reduced M2-like phenotype of microglia (CX3CR1 and CD200R) via their specific pathway, which may be involved in stress vulnerability and depression.
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